Skip to main content
FBRX logo

Forte Biosciences, Inc.

FBRXNASDAQHealthcareBiotechnology

$76.99Today:- (-)1Y +537.33%

As of Aug 28, 2026 close

Market cap
$1.83B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$10.30$77.20
Volume (live)
-
Avg. volume (3M)
1.82M

Forte Biosciences, Inc. (FBRX) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Forte Biosciences, Inc. stock.

Analyst Consensus Rating

Investment consensus from 5 professional research analysts

Consensus Rating

Hold
Based on 5 unique analysts
Medium Confidence0

Average Price Target

$77.00
+0.01% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest FBRX Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Etzer Darout
Barclays
HoldReiterates
$77.00
Kumaraguru Raja
Brookline Capital
HoldDowngrades
$77.00
Edmund Ingham
Forbes
SellInitiates Coverage
-
Yaron Werber
TD Cowen
HoldDowngrades
$77.00
Gavin Clark-Gartner
Evercore ISI Group
HoldDowngrades
$69.00 → $77.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Aug 13, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for FBRX?

The analyst consensus rating for FBRX is Hold, based on the latest ratings from 5 analysts over the last 90 days.

What is the average price target for FBRX?

The average 12-month price target for FBRX is $77.00, representing an upside of 0.0% from the Aug 28, 2026 close of $76.99.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.